Period of time： 2004年3期
Publisher： Elsevier
Founded in： 1977
Total resources： 4
ISSN： 0145-2126
Subject： R3 Basic Medical
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Leukemia Research,volume 28,issue 3
Menu
Tyrosine kinases in AML: where do they fit in?
Leukemia Research,volume 28,issue 3 , Vol. 28, Iss. 3, 2004-03 , pp.
Access to resources
Recommend
Comparative gene expression profile of p185 Bcr-Abl versus p210 Bcr-Abl expressing cells
By Tipping A.J., Melo J.V. in (2004)
Leukemia Research,volume 28,issue 3 , Vol. 28, Iss. 3, 2004-03 , pp.The angiogenic status of B-CLL B cells: role of the VEGF receptors
Leukemia Research,volume 28,issue 3 , Vol. 28, Iss. 3, 2004-03 , pp.Treatment of systemic mast cell disease: beyond interferon
Leukemia Research,volume 28,issue 3 , Vol. 28, Iss. 3, 2004-03 , pp.A novel EBV-negative natural killer cell line
Leukemia Research,volume 28,issue 3 , Vol. 28, Iss. 3, 2004-03 , pp.By Aki H., Tuzuner N., Ongoren S., Baslar Z., Soysal T., Ferhanoglu B., Sahinler I., Aydin Y., Ulku B., Aktuglu G. in (2004)
Leukemia Research,volume 28,issue 3 , Vol. 28, Iss. 3, 2004-03 , pp.The soluble form of CD83 is present at elevated levels in a number of hematological malignancies
By Hock B.D., Haring L.F., Steinkasserer A., Taylor K.G., Patton W.N., McKenzie J.L. in (2004)
Leukemia Research,volume 28,issue 3 , Vol. 28, Iss. 3, 2004-03 , pp.By Bairey O., Boycov O., Kaganovsky E., Zimra Y., Shaklai M., Rabizadeh E. in (2004)
Leukemia Research,volume 28,issue 3 , Vol. 28, Iss. 3, 2004-03 , pp.By Hauswirth A.W., Simonitsch-Klupp I., Uffmann M., Koller E., Sperr W.R., Lechner K., Valent P. in (2004)
Leukemia Research,volume 28,issue 3 , Vol. 28, Iss. 3, 2004-03 , pp.By Alexandrakis M.G., Passam F.H., Sfiridaki K., Moschandrea J., Pappa C., Liapi D., Petreli E., Roussou P., Kyriakou D.S. in (2004)
Leukemia Research,volume 28,issue 3 , Vol. 28, Iss. 3, 2004-03 , pp.
Previous
Next